Abstract
BackgroundSLE is a heterogenous autoimmune disease that is characterised by diverse clinical manifestations and target tissue damage. The prevalence of SLE is estimated to be between 40 and 400 cases...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
